E2F1 and lung adenocarcinoma: Functional connectivity of the top network revealed a strong over-representation of the E2F1 pathway in patients in the F subgroup (Fig. S4), suggesting that its activation may be a key genetic determinant associated with the poorer survival of lung adenocarcinoma patients in this subgroup.